Latest Innovation News

Beonic's Q2 FY2025 results reveal steady recurring revenue growth and a significant gross margin improvement, underpinning its path to cashflow breakeven. Strategic contract wins and leadership appointments position the company for accelerated IoT adoption.

Live Verdure Ltd has secured a controlling stake in AI innovator Decidr.ai and reported robust e-commerce growth for its Edible Beauty brand, underscoring its strategic pivot towards AI-driven expansion.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.

Adherium reports strong patient adoption and new US partnerships, positioning for significant expansion in 2025 with a target of 9,000 active users and entry into the Pharmacy Benefit Management sector.

Telix Pharmaceuticals has completed a strategic acquisition of ImaginAb, gaining next-generation therapeutic assets and a novel biologics platform to expand its oncology pipeline and R&D capabilities.

Loyal Lithium Limited has consolidated its position in North America’s lithium sector through a key acquisition and promising exploration results, positioning itself strongly for 2025.

Norwood Systems has secured a fifth variation to its cash drawdown facility, increasing the principal to $720,114 and extending repayment to mid-February 2025. The move underscores ongoing financial support from a key director amid evolving capital needs.

Earth's Energy Limited reports promising progress in its Paralana and Flinders West geothermal projects, confirming new development zones and initiating joint venture discussions, while maintaining a solid cash position.

Aeeris Ltd reported solid growth in Q2 FY25, driven by increased annual recurring revenue and new contracts across key sectors, while unveiling a promising new technology set to expand its market footprint.

Ramsay Health Care announces key leadership departures and a strategic realignment aimed at strengthening its core Australian hospital business and accelerating transformation under CEO Natalie Davis.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

BirdDog Technology reports a strategic pivot with four next-generation product launches, a 20% price increase, and a robust cash position, despite a 13% revenue decline in H1 FY25.